Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROCIEP: Oral Idarubicin Regimen for Elderly NHL
NCT01958996Phase 2Completed
- Sponsor
- CHU de Poitiers
- Start
- Jan 2009
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idarubicin in diffuse large B-cell lymphoma (DLBCL), sponsored by CHU de Poitiers. Started Jan 2009; status: completed.
02
Drugs
idarubicin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01958996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01958996.